These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27350117)

  • 1. Mycobacterium tuberculosis lipoproteins in virulence and immunity - fighting with a double-edged sword.
    Becker K; Sander P
    FEBS Lett; 2016 Nov; 590(21):3800-3819. PubMed ID: 27350117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein processing is required for virulence of Mycobacterium tuberculosis.
    Sander P; Rezwan M; Walker B; Rampini SK; Kroppenstedt RM; Ehlers S; Keller C; Keeble JR; Hagemeier M; Colston MJ; Springer B; Böttger EC
    Mol Microbiol; 2004 Jun; 52(6):1543-52. PubMed ID: 15186407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoproteins of slow-growing Mycobacteria carry three fatty acids and are N-acylated by apolipoprotein N-acyltransferase BCG_2070c.
    Brülle JK; Tschumi A; Sander P
    BMC Microbiol; 2013 Oct; 13():223. PubMed ID: 24093492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs.
    Sakthi S; Palaniyandi K; Gupta UD; Gupta P; Narayanan S
    Vaccine; 2016 Feb; 34(6):735-43. PubMed ID: 26768127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoproteins are major targets of the polyclonal human T cell response to Mycobacterium tuberculosis.
    Seshadri C; Turner MT; Lewinsohn DM; Moody DB; Van Rhijn I
    J Immunol; 2013 Jan; 190(1):278-84. PubMed ID: 23197260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory action of mycobacterial secretory proteins.
    Trajkovic V; Natarajan K; Sharma P
    Microbes Infect; 2004 Apr; 6(5):513-9. PubMed ID: 15109967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning, expression and characterization of Mycobacterium tuberculosis lipoprotein LprF.
    Brülle JK; Grau T; Tschumi A; Auchli Y; Burri R; Polsfuss S; Keller PM; Hunziker P; Sander P
    Biochem Biophys Res Commun; 2010 Jan; 391(1):679-84. PubMed ID: 19944079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Search for new tuberculosis vaccines].
    Gicquel B
    Bull Acad Natl Med; 1999; 183(7):53-61; discussion 61-2. PubMed ID: 10622122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein synthesis in mycobacteria.
    Rezwan M; Grau T; Tschumi A; Sander P
    Microbiology (Reading); 2007 Mar; 153(Pt 3):652-658. PubMed ID: 17322184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization and preliminary X-ray crystallographic analysis of the 38-kDa immunodominant antigen of Mycobacterium tuberculosis.
    Choudhary A; Vyas MN; Vyas NK; Chang Z; Quiocho FA
    Protein Sci; 1994 Dec; 3(12):2450-1. PubMed ID: 7756999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components.
    Sutcliffe IC; Harrington DJ
    FEMS Microbiol Rev; 2004 Nov; 28(5):645-59. PubMed ID: 15539077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route.
    Gupta A; Geetha N; Mani J; Upadhyay P; Katoch VM; Natrajan M; Gupta UD; Bhaskar S
    Infect Immun; 2009 Jan; 77(1):223-31. PubMed ID: 18981249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective and survival efficacies of Rv0160c protein in murine model of Mycobacterium tuberculosis.
    Singh SK; Tripathi DK; Singh PK; Sharma S; Srivastava KK
    Appl Microbiol Biotechnol; 2013 Jul; 97(13):5825-37. PubMed ID: 23104642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lpqS knockout mutant of Mycobacterium tuberculosis is attenuated in macrophages.
    Sakthi S; Narayanan S
    Microbiol Res; 2013 Aug; 168(7):407-14. PubMed ID: 23562345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
    Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
    Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein antigens of Mycobacterium tuberculosis.
    Young DB; Garbe TR
    Res Microbiol; 1991 Jan; 142(1):55-65. PubMed ID: 1906192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.